Liabilities	12 Months Ended
Dec. 28, 2018
Debt Disclosure [Abstract]
Liabilities	Note 8 — Liabilities Lines of Credit Since 1998, the Company’s wholly owned Japanese subsidiary, STAAR Japan, has had an agreement with Mizuho Bank which provides for borrowings of up to 500,000,000 Yen, at an interest rate equal to the uncollateralized overnight call rate (approximately 0.06% as of December 28, 2018) plus a 0.50% spread, and may be renewed quarterly (the current line expires on February 21, 2019). The credit facility is not collateralized. The Company had 417,500,000 Yen and 500,000,000 Yen outstanding on the line of credit as of December 28, 2018 and December 29, 2017, respectively (approximately $3,780,000 and $4,438,000 based on the foreign exchange rates on December 28, 2018 and December 29, 2017, respectively), which approximates fair value due to the short-term maturity and market interest rates of the line of credit. In case of default, the interest rate will be increased to 14% per annum. As of December 28, 2018, there was 82,500,000 Yen (approximately $747,000 based on the foreign exchange rate on December 28, 2018) available for borrowing and as of December 29, 2017 there were no available borrowings under the line. At maturity on February 21, 2019, this line of credit is intended to be renewed until May 21, 2019, with similar terms. Note 8 — Liabilities (Continued) Lines of Credit (Continued) In September 2013, the Company’s wholly owned Swiss subsidiary, STAAR Surgical AG, entered into a framework agreement for loans (“framework agreement”) with Credit Suisse (the “Bank”). The framework agreement provides for borrowings of up to 1,000,000 CHF (Swiss Francs) (approximately $1,000,000 at the rate of exchange on December 28, 2018 and December 29, 2017), to be used for working capital purposes. Accrued interest and 0.25% commissions on average outstanding borrowings is payable quarterly and the interest rate will be determined by the Bank based on the then prevailing market conditions at the time of borrowing. The framework agreement is automatically renewed on an annual basis based on the same terms assuming there is no default. The framework agreement may be terminated by either party at any time in accordance with its general terms and conditions. The framework agreement is not collateralized and contains certain conditions such as providing the Bank with audited financial statements annually and notice of significant events or conditions, as defined in the framework agreement. The Bank may also declare all amounts outstanding to be immediately due and payable upon a change of control or a “material qualification” in STAAR Surgical independent auditors’ report, as defined. There were no borrowings outstanding as of December 28, 2018 and December 29, 2017. Covenant Compliance The Company is in compliance with covenants of its credit facilities and lines of credit as of December 28, 2018. Lease Line of Credit (Capital Leases) On March 8, 2018, the Company entered into lease schedule 011 with Farnam Street Financial, Inc. (“Farnam”). The line of credit provides for borrowings of up to $500,000 at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. Interim rent is paid until the full amount of the line is used at which time the lease commences. As of December 28, 2018, approximately $387,000 of the line was available for borrowing. On March 8, 2018, the Company entered into lease schedule 010R with Farnam. Under 010R, equipment with a cost of $1,560,000 was financed over a period of 24 months at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. At the end of the lease the Company can opt to continue to rent the equipment, return the equipment, or exercise a fair market value purchase option. As of December 28, 2018, approximately $864,000 was outstanding on this capital lease. On January 31, 2017, the Company entered into lease schedule 009R with Farnam. Under 009R, equipment with a cost of $1,957,000 was financed over a period of 24 months at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. At the end of the lease the Company can opt to continue to rent the equipment, return the equipment, or exercise a fair market value purchase option. As of December 28, 2018 and December 29, 2017, approximately $83,000 and $1,067,000, respectively, was outstanding on this capital lease. Asset Retirement Obligation The Company recorded certain Asset Retirement Obligations (“ARO”), in accordance with ASC 410-20 in connection with the Company’s obligation to return its Japan facility to its “original condition”, as defined in the lease agreement. The Company has recorded approximately $206,000 and $202,000, representing the fair value of the ARO liability obligation in noncurrent liabilities at December 28, 2018 and December 29, 2017, respectively. The lease expires in 2019, however, the Company has no plans to vacate the facility and has started negotiations during 2019 to extend the lease beyond 2019.

Liabilities

12 Months Ended

Dec. 28, 2018

Note 8 — Liabilities

Lines of Credit

Since 1998, the Company’s wholly owned Japanese subsidiary, STAAR Japan, has had an agreement with Mizuho Bank which provides for borrowings of up to 500,000,000 Yen, at an interest rate equal to the uncollateralized overnight call rate (approximately 0.06% as of December 28, 2018) plus a 0.50% spread, and may be renewed quarterly (the current line expires on February 21, 2019). The credit facility is not collateralized. The Company had 417,500,000 Yen and 500,000,000 Yen outstanding on the line of credit as of December 28, 2018 and December 29, 2017, respectively (approximately $3,780,000 and $4,438,000 based on the foreign exchange rates on December 28, 2018 and December 29, 2017, respectively), which approximates fair value due to the short-term maturity and market interest rates of the line of credit. In case of default, the interest rate will be increased to 14% per annum. As of December 28, 2018, there was 82,500,000 Yen (approximately $747,000 based on the foreign exchange rate on December 28, 2018) available for borrowing and as of December 29, 2017 there were no available borrowings under the line. At maturity on February 21, 2019, this line of credit is intended to be renewed until May 21, 2019, with similar terms.

Note 8 — Liabilities (Continued)

Lines of Credit (Continued)

In September 2013, the Company’s wholly owned Swiss subsidiary, STAAR Surgical AG, entered into a framework agreement for loans (“framework agreement”) with Credit Suisse (the “Bank”). The framework agreement provides for borrowings of up to 1,000,000 CHF (Swiss Francs) (approximately $1,000,000 at the rate of exchange on December 28, 2018 and December 29, 2017), to be used for working capital purposes. Accrued interest and 0.25% commissions on average outstanding borrowings is payable quarterly and the interest rate will be determined by the Bank based on the then prevailing market conditions at the time of borrowing. The framework agreement is automatically renewed on an annual basis based on the same terms assuming there is no default. The framework agreement may be terminated by either party at any time in accordance with its general terms and conditions. The framework agreement is not collateralized and contains certain conditions such as providing the Bank with audited financial statements annually and notice of significant events or conditions, as defined in the framework agreement. The Bank may also declare all amounts outstanding to be immediately due and payable upon a change of control or a “material qualification” in STAAR Surgical independent auditors’ report, as defined. There were no borrowings outstanding as of December 28, 2018 and December 29, 2017.

Covenant Compliance

The Company is in compliance with covenants of its credit facilities and lines of credit as of December 28, 2018.

Lease Line of Credit (Capital Leases)

On March 8, 2018, the Company entered into lease schedule 011 with Farnam Street Financial, Inc. (“Farnam”). The line of credit provides for borrowings of up to $500,000 at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. Interim rent is paid until the full amount of the line is used at which time the lease commences. As of December 28, 2018, approximately $387,000 of the line was available for borrowing.

On March 8, 2018, the Company entered into lease schedule 010R with Farnam. Under 010R, equipment with a cost of $1,560,000 was financed over a period of 24 months at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. At the end of the lease the Company can opt to continue to rent the equipment, return the equipment, or exercise a fair market value purchase option. As of December 28, 2018, approximately $864,000 was outstanding on this capital lease.

On January 31, 2017, the Company entered into lease schedule 009R with Farnam. Under 009R, equipment with a cost of $1,957,000 was financed over a period of 24 months at a lease rate factor of 3.94% per $1 for hardware equipment and 4.75% per $1 for non-hardware equipment. At the end of the lease the Company can opt to continue to rent the equipment, return the equipment, or exercise a fair market value purchase option. As of December 28, 2018 and December 29, 2017, approximately $83,000 and $1,067,000, respectively, was outstanding on this capital lease.

Asset Retirement Obligation

The Company recorded certain Asset Retirement Obligations (“ARO”), in accordance with ASC 410-20 in connection with the Company’s obligation to return its Japan facility to its “original condition”, as defined in the lease agreement. The Company has recorded approximately $206,000 and $202,000, representing the fair value of the ARO liability obligation in noncurrent liabilities at December 28, 2018 and December 29, 2017, respectively. The lease expires in 2019, however, the Company has no plans to vacate the facility and has started negotiations during 2019 to extend the lease beyond 2019.